Fine-Tuning Cardiac Insulin-Like Growth Factor 1 Receptor Signaling to Promote Health and Longevity
The insulin-like growth factor 1 (IGF1) pathway is a key regulator of cellular metabolism and aging. Although its inhibition promotes longevity across species, the effect of attenuated IGF1 signaling on cardiac aging remains controversial. We performed a lifelong study to assess cardiac health and l...
Gespeichert in:
Veröffentlicht in: | Circulation (New York, N.Y.) N.Y.), 2022-06, Vol.145 (25), p.1853-1866 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1866 |
---|---|
container_issue | 25 |
container_start_page | 1853 |
container_title | Circulation (New York, N.Y.) |
container_volume | 145 |
creator | Abdellatif, Mahmoud Trummer-Herbst, Viktoria Heberle, Alexander Martin Humnig, Alina Pendl, Tobias Durand, Sylvère Cerrato, Giulia Hofer, Sebastian J. Islam, Moydul Voglhuber, Julia Ramos Pittol, José Miguel Kepp, Oliver Hoefler, Gerald Schmidt, Albrecht Rainer, Peter P. Scherr, Daniel von Lewinski, Dirk Bisping, Egbert McMullen, Julie R. Diwan, Abhinav Eisenberg, Tobias Madeo, Frank Thedieck, Kathrin Kroemer, Guido Sedej, Simon |
description | The insulin-like growth factor 1 (IGF1) pathway is a key regulator of cellular metabolism and aging. Although its inhibition promotes longevity across species, the effect of attenuated IGF1 signaling on cardiac aging remains controversial.
We performed a lifelong study to assess cardiac health and lifespan in 2 cardiomyocyte-specific transgenic mouse models with enhanced versus reduced IGF1 receptor (IGF1R) signaling. Male mice with human IGF1R overexpression or dominant negative phosphoinositide 3-kinase mutation were examined at different life stages by echocardiography, invasive hemodynamics, and treadmill coupled to indirect calorimetry. In vitro assays included cardiac histology, mitochondrial respiration, ATP synthesis, autophagic flux, and targeted metabolome profiling, and immunoblots of key IGF1R downstream targets in mouse and human explanted failing and nonfailing hearts, as well.
Young mice with increased IGF1R signaling exhibited superior cardiac function that progressively declined with aging in an accelerated fashion compared with wild-type animals, resulting in heart failure and a reduced lifespan. In contrast, mice with low cardiac IGF1R signaling exhibited inferior cardiac function early in life, but superior cardiac performance during aging, and increased maximum lifespan, as well. Mechanistically, the late-life detrimental effects of IGF1R activation correlated with suppressed autophagic flux and impaired oxidative phosphorylation in the heart. Low IGF1R activity consistently improved myocardial bioenergetics and function of the aging heart in an autophagy-dependent manner. In humans, failing hearts, but not those with compensated hypertrophy, displayed exaggerated IGF1R expression and signaling activity.
Our findings indicate that the relationship between IGF1R signaling and cardiac health is not linear, but rather biphasic. Hence, pharmacological inhibitors of the IGF1 pathway, albeit unsuitable for young individuals, might be worth considering in older adults. |
doi_str_mv | 10.1161/CIRCULATIONAHA.122.059863 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9203038</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2670061440</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5026-ecbe975d07bafe26752a928194f4a4d713dabb4ed767c7ce5a3c660c529d68c83</originalsourceid><addsrcrecordid>eNpdkl9v0zAUxSMEYmXwFVB4g4cU27Gd-AUpita1UsTQ6J4tx7ltzVK72EmrfXvcZUyMJ_8751xf_5wknzCaY8zx13p1W9811Xp1871aVnNMyBwxUfL8VTLDjNCMsly8TmYIIZEVOSEXybsQfsUlzwv2NrnIGcccsXKW6IWxkK1Ha-w2rZXvjNLpyoaxNzZrzD2k196dhl26UHpwPsXpLWg4nKc_zdaq_uwbXPrDu70bIF2C6qNa2S5tnN3C0QwP75M3G9UH-PA0XiZ3i6t1vcyam-tVXTWZZojwDHQLomAdKlq1AcILRpQgJRZ0QxXtCpx3qm0pdAUvdKGBqVxzjjQjouOlLvPL5NuUexjbPXQa7OBVLw_e7JV_kE4Z-fLEmp3cuqMUBOUoPwd8mQJ2_9mWVSPPe4gyEUvSI47az0_FvPs9Qhjk3gQNfa8suDHIeP_43JhSFKVikmrvQvCwec7GSJ6BypdAZQQqJ6DR-_Hfnp6dfwlGAZ0EJ9cP4MN9P57Ay90jBxmRx9ZwkRFECOIEoww9foM_B92t_w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2670061440</pqid></control><display><type>article</type><title>Fine-Tuning Cardiac Insulin-Like Growth Factor 1 Receptor Signaling to Promote Health and Longevity</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Abdellatif, Mahmoud ; Trummer-Herbst, Viktoria ; Heberle, Alexander Martin ; Humnig, Alina ; Pendl, Tobias ; Durand, Sylvère ; Cerrato, Giulia ; Hofer, Sebastian J. ; Islam, Moydul ; Voglhuber, Julia ; Ramos Pittol, José Miguel ; Kepp, Oliver ; Hoefler, Gerald ; Schmidt, Albrecht ; Rainer, Peter P. ; Scherr, Daniel ; von Lewinski, Dirk ; Bisping, Egbert ; McMullen, Julie R. ; Diwan, Abhinav ; Eisenberg, Tobias ; Madeo, Frank ; Thedieck, Kathrin ; Kroemer, Guido ; Sedej, Simon</creator><creatorcontrib>Abdellatif, Mahmoud ; Trummer-Herbst, Viktoria ; Heberle, Alexander Martin ; Humnig, Alina ; Pendl, Tobias ; Durand, Sylvère ; Cerrato, Giulia ; Hofer, Sebastian J. ; Islam, Moydul ; Voglhuber, Julia ; Ramos Pittol, José Miguel ; Kepp, Oliver ; Hoefler, Gerald ; Schmidt, Albrecht ; Rainer, Peter P. ; Scherr, Daniel ; von Lewinski, Dirk ; Bisping, Egbert ; McMullen, Julie R. ; Diwan, Abhinav ; Eisenberg, Tobias ; Madeo, Frank ; Thedieck, Kathrin ; Kroemer, Guido ; Sedej, Simon</creatorcontrib><description>The insulin-like growth factor 1 (IGF1) pathway is a key regulator of cellular metabolism and aging. Although its inhibition promotes longevity across species, the effect of attenuated IGF1 signaling on cardiac aging remains controversial.
We performed a lifelong study to assess cardiac health and lifespan in 2 cardiomyocyte-specific transgenic mouse models with enhanced versus reduced IGF1 receptor (IGF1R) signaling. Male mice with human IGF1R overexpression or dominant negative phosphoinositide 3-kinase mutation were examined at different life stages by echocardiography, invasive hemodynamics, and treadmill coupled to indirect calorimetry. In vitro assays included cardiac histology, mitochondrial respiration, ATP synthesis, autophagic flux, and targeted metabolome profiling, and immunoblots of key IGF1R downstream targets in mouse and human explanted failing and nonfailing hearts, as well.
Young mice with increased IGF1R signaling exhibited superior cardiac function that progressively declined with aging in an accelerated fashion compared with wild-type animals, resulting in heart failure and a reduced lifespan. In contrast, mice with low cardiac IGF1R signaling exhibited inferior cardiac function early in life, but superior cardiac performance during aging, and increased maximum lifespan, as well. Mechanistically, the late-life detrimental effects of IGF1R activation correlated with suppressed autophagic flux and impaired oxidative phosphorylation in the heart. Low IGF1R activity consistently improved myocardial bioenergetics and function of the aging heart in an autophagy-dependent manner. In humans, failing hearts, but not those with compensated hypertrophy, displayed exaggerated IGF1R expression and signaling activity.
Our findings indicate that the relationship between IGF1R signaling and cardiac health is not linear, but rather biphasic. Hence, pharmacological inhibitors of the IGF1 pathway, albeit unsuitable for young individuals, might be worth considering in older adults.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/CIRCULATIONAHA.122.059863</identifier><identifier>PMID: 35616058</identifier><language>eng</language><publisher>United States: Lippincott Williams & Wilkins</publisher><subject>Aged ; Animals ; Health Promotion ; Humans ; Insulin-Like Growth Factor I - metabolism ; Life Sciences ; Longevity ; Male ; Mice ; Myocytes, Cardiac - metabolism ; Original s ; Phosphatidylinositol 3-Kinases - metabolism ; Receptor, IGF Type 1 - genetics ; Receptor, IGF Type 1 - metabolism</subject><ispartof>Circulation (New York, N.Y.), 2022-06, Vol.145 (25), p.1853-1866</ispartof><rights>Lippincott Williams & Wilkins</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>2022 The Authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5026-ecbe975d07bafe26752a928194f4a4d713dabb4ed767c7ce5a3c660c529d68c83</citedby><cites>FETCH-LOGICAL-c5026-ecbe975d07bafe26752a928194f4a4d713dabb4ed767c7ce5a3c660c529d68c83</cites><orcidid>0000-0001-6414-8707 ; 0000-0003-4623-0330 ; 0000-0003-0102-7902 ; 0000-0003-2755-2860 ; 0000-0003-3559-1130 ; 0000-0002-3828-9562 ; 0000-0002-4419-6821 ; 0000-0002-5042-9054 ; 0000-0002-2840-6454 ; 0000-0002-9334-4405 ; 0000-0002-6081-9558 ; 0000-0002-0756-0014 ; 0000-0003-3753-5394 ; 0000-0002-9069-2930</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,3687,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35616058$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04596604$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Abdellatif, Mahmoud</creatorcontrib><creatorcontrib>Trummer-Herbst, Viktoria</creatorcontrib><creatorcontrib>Heberle, Alexander Martin</creatorcontrib><creatorcontrib>Humnig, Alina</creatorcontrib><creatorcontrib>Pendl, Tobias</creatorcontrib><creatorcontrib>Durand, Sylvère</creatorcontrib><creatorcontrib>Cerrato, Giulia</creatorcontrib><creatorcontrib>Hofer, Sebastian J.</creatorcontrib><creatorcontrib>Islam, Moydul</creatorcontrib><creatorcontrib>Voglhuber, Julia</creatorcontrib><creatorcontrib>Ramos Pittol, José Miguel</creatorcontrib><creatorcontrib>Kepp, Oliver</creatorcontrib><creatorcontrib>Hoefler, Gerald</creatorcontrib><creatorcontrib>Schmidt, Albrecht</creatorcontrib><creatorcontrib>Rainer, Peter P.</creatorcontrib><creatorcontrib>Scherr, Daniel</creatorcontrib><creatorcontrib>von Lewinski, Dirk</creatorcontrib><creatorcontrib>Bisping, Egbert</creatorcontrib><creatorcontrib>McMullen, Julie R.</creatorcontrib><creatorcontrib>Diwan, Abhinav</creatorcontrib><creatorcontrib>Eisenberg, Tobias</creatorcontrib><creatorcontrib>Madeo, Frank</creatorcontrib><creatorcontrib>Thedieck, Kathrin</creatorcontrib><creatorcontrib>Kroemer, Guido</creatorcontrib><creatorcontrib>Sedej, Simon</creatorcontrib><title>Fine-Tuning Cardiac Insulin-Like Growth Factor 1 Receptor Signaling to Promote Health and Longevity</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>The insulin-like growth factor 1 (IGF1) pathway is a key regulator of cellular metabolism and aging. Although its inhibition promotes longevity across species, the effect of attenuated IGF1 signaling on cardiac aging remains controversial.
We performed a lifelong study to assess cardiac health and lifespan in 2 cardiomyocyte-specific transgenic mouse models with enhanced versus reduced IGF1 receptor (IGF1R) signaling. Male mice with human IGF1R overexpression or dominant negative phosphoinositide 3-kinase mutation were examined at different life stages by echocardiography, invasive hemodynamics, and treadmill coupled to indirect calorimetry. In vitro assays included cardiac histology, mitochondrial respiration, ATP synthesis, autophagic flux, and targeted metabolome profiling, and immunoblots of key IGF1R downstream targets in mouse and human explanted failing and nonfailing hearts, as well.
Young mice with increased IGF1R signaling exhibited superior cardiac function that progressively declined with aging in an accelerated fashion compared with wild-type animals, resulting in heart failure and a reduced lifespan. In contrast, mice with low cardiac IGF1R signaling exhibited inferior cardiac function early in life, but superior cardiac performance during aging, and increased maximum lifespan, as well. Mechanistically, the late-life detrimental effects of IGF1R activation correlated with suppressed autophagic flux and impaired oxidative phosphorylation in the heart. Low IGF1R activity consistently improved myocardial bioenergetics and function of the aging heart in an autophagy-dependent manner. In humans, failing hearts, but not those with compensated hypertrophy, displayed exaggerated IGF1R expression and signaling activity.
Our findings indicate that the relationship between IGF1R signaling and cardiac health is not linear, but rather biphasic. Hence, pharmacological inhibitors of the IGF1 pathway, albeit unsuitable for young individuals, might be worth considering in older adults.</description><subject>Aged</subject><subject>Animals</subject><subject>Health Promotion</subject><subject>Humans</subject><subject>Insulin-Like Growth Factor I - metabolism</subject><subject>Life Sciences</subject><subject>Longevity</subject><subject>Male</subject><subject>Mice</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Original s</subject><subject>Phosphatidylinositol 3-Kinases - metabolism</subject><subject>Receptor, IGF Type 1 - genetics</subject><subject>Receptor, IGF Type 1 - metabolism</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkl9v0zAUxSMEYmXwFVB4g4cU27Gd-AUpita1UsTQ6J4tx7ltzVK72EmrfXvcZUyMJ_8751xf_5wknzCaY8zx13p1W9811Xp1871aVnNMyBwxUfL8VTLDjNCMsly8TmYIIZEVOSEXybsQfsUlzwv2NrnIGcccsXKW6IWxkK1Ha-w2rZXvjNLpyoaxNzZrzD2k196dhl26UHpwPsXpLWg4nKc_zdaq_uwbXPrDu70bIF2C6qNa2S5tnN3C0QwP75M3G9UH-PA0XiZ3i6t1vcyam-tVXTWZZojwDHQLomAdKlq1AcILRpQgJRZ0QxXtCpx3qm0pdAUvdKGBqVxzjjQjouOlLvPL5NuUexjbPXQa7OBVLw_e7JV_kE4Z-fLEmp3cuqMUBOUoPwd8mQJ2_9mWVSPPe4gyEUvSI47az0_FvPs9Qhjk3gQNfa8suDHIeP_43JhSFKVikmrvQvCwec7GSJ6BypdAZQQqJ6DR-_Hfnp6dfwlGAZ0EJ9cP4MN9P57Ay90jBxmRx9ZwkRFECOIEoww9foM_B92t_w</recordid><startdate>20220621</startdate><enddate>20220621</enddate><creator>Abdellatif, Mahmoud</creator><creator>Trummer-Herbst, Viktoria</creator><creator>Heberle, Alexander Martin</creator><creator>Humnig, Alina</creator><creator>Pendl, Tobias</creator><creator>Durand, Sylvère</creator><creator>Cerrato, Giulia</creator><creator>Hofer, Sebastian J.</creator><creator>Islam, Moydul</creator><creator>Voglhuber, Julia</creator><creator>Ramos Pittol, José Miguel</creator><creator>Kepp, Oliver</creator><creator>Hoefler, Gerald</creator><creator>Schmidt, Albrecht</creator><creator>Rainer, Peter P.</creator><creator>Scherr, Daniel</creator><creator>von Lewinski, Dirk</creator><creator>Bisping, Egbert</creator><creator>McMullen, Julie R.</creator><creator>Diwan, Abhinav</creator><creator>Eisenberg, Tobias</creator><creator>Madeo, Frank</creator><creator>Thedieck, Kathrin</creator><creator>Kroemer, Guido</creator><creator>Sedej, Simon</creator><general>Lippincott Williams & Wilkins</general><general>American Heart Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6414-8707</orcidid><orcidid>https://orcid.org/0000-0003-4623-0330</orcidid><orcidid>https://orcid.org/0000-0003-0102-7902</orcidid><orcidid>https://orcid.org/0000-0003-2755-2860</orcidid><orcidid>https://orcid.org/0000-0003-3559-1130</orcidid><orcidid>https://orcid.org/0000-0002-3828-9562</orcidid><orcidid>https://orcid.org/0000-0002-4419-6821</orcidid><orcidid>https://orcid.org/0000-0002-5042-9054</orcidid><orcidid>https://orcid.org/0000-0002-2840-6454</orcidid><orcidid>https://orcid.org/0000-0002-9334-4405</orcidid><orcidid>https://orcid.org/0000-0002-6081-9558</orcidid><orcidid>https://orcid.org/0000-0002-0756-0014</orcidid><orcidid>https://orcid.org/0000-0003-3753-5394</orcidid><orcidid>https://orcid.org/0000-0002-9069-2930</orcidid></search><sort><creationdate>20220621</creationdate><title>Fine-Tuning Cardiac Insulin-Like Growth Factor 1 Receptor Signaling to Promote Health and Longevity</title><author>Abdellatif, Mahmoud ; Trummer-Herbst, Viktoria ; Heberle, Alexander Martin ; Humnig, Alina ; Pendl, Tobias ; Durand, Sylvère ; Cerrato, Giulia ; Hofer, Sebastian J. ; Islam, Moydul ; Voglhuber, Julia ; Ramos Pittol, José Miguel ; Kepp, Oliver ; Hoefler, Gerald ; Schmidt, Albrecht ; Rainer, Peter P. ; Scherr, Daniel ; von Lewinski, Dirk ; Bisping, Egbert ; McMullen, Julie R. ; Diwan, Abhinav ; Eisenberg, Tobias ; Madeo, Frank ; Thedieck, Kathrin ; Kroemer, Guido ; Sedej, Simon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5026-ecbe975d07bafe26752a928194f4a4d713dabb4ed767c7ce5a3c660c529d68c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aged</topic><topic>Animals</topic><topic>Health Promotion</topic><topic>Humans</topic><topic>Insulin-Like Growth Factor I - metabolism</topic><topic>Life Sciences</topic><topic>Longevity</topic><topic>Male</topic><topic>Mice</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Original s</topic><topic>Phosphatidylinositol 3-Kinases - metabolism</topic><topic>Receptor, IGF Type 1 - genetics</topic><topic>Receptor, IGF Type 1 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abdellatif, Mahmoud</creatorcontrib><creatorcontrib>Trummer-Herbst, Viktoria</creatorcontrib><creatorcontrib>Heberle, Alexander Martin</creatorcontrib><creatorcontrib>Humnig, Alina</creatorcontrib><creatorcontrib>Pendl, Tobias</creatorcontrib><creatorcontrib>Durand, Sylvère</creatorcontrib><creatorcontrib>Cerrato, Giulia</creatorcontrib><creatorcontrib>Hofer, Sebastian J.</creatorcontrib><creatorcontrib>Islam, Moydul</creatorcontrib><creatorcontrib>Voglhuber, Julia</creatorcontrib><creatorcontrib>Ramos Pittol, José Miguel</creatorcontrib><creatorcontrib>Kepp, Oliver</creatorcontrib><creatorcontrib>Hoefler, Gerald</creatorcontrib><creatorcontrib>Schmidt, Albrecht</creatorcontrib><creatorcontrib>Rainer, Peter P.</creatorcontrib><creatorcontrib>Scherr, Daniel</creatorcontrib><creatorcontrib>von Lewinski, Dirk</creatorcontrib><creatorcontrib>Bisping, Egbert</creatorcontrib><creatorcontrib>McMullen, Julie R.</creatorcontrib><creatorcontrib>Diwan, Abhinav</creatorcontrib><creatorcontrib>Eisenberg, Tobias</creatorcontrib><creatorcontrib>Madeo, Frank</creatorcontrib><creatorcontrib>Thedieck, Kathrin</creatorcontrib><creatorcontrib>Kroemer, Guido</creatorcontrib><creatorcontrib>Sedej, Simon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abdellatif, Mahmoud</au><au>Trummer-Herbst, Viktoria</au><au>Heberle, Alexander Martin</au><au>Humnig, Alina</au><au>Pendl, Tobias</au><au>Durand, Sylvère</au><au>Cerrato, Giulia</au><au>Hofer, Sebastian J.</au><au>Islam, Moydul</au><au>Voglhuber, Julia</au><au>Ramos Pittol, José Miguel</au><au>Kepp, Oliver</au><au>Hoefler, Gerald</au><au>Schmidt, Albrecht</au><au>Rainer, Peter P.</au><au>Scherr, Daniel</au><au>von Lewinski, Dirk</au><au>Bisping, Egbert</au><au>McMullen, Julie R.</au><au>Diwan, Abhinav</au><au>Eisenberg, Tobias</au><au>Madeo, Frank</au><au>Thedieck, Kathrin</au><au>Kroemer, Guido</au><au>Sedej, Simon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fine-Tuning Cardiac Insulin-Like Growth Factor 1 Receptor Signaling to Promote Health and Longevity</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2022-06-21</date><risdate>2022</risdate><volume>145</volume><issue>25</issue><spage>1853</spage><epage>1866</epage><pages>1853-1866</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><abstract>The insulin-like growth factor 1 (IGF1) pathway is a key regulator of cellular metabolism and aging. Although its inhibition promotes longevity across species, the effect of attenuated IGF1 signaling on cardiac aging remains controversial.
We performed a lifelong study to assess cardiac health and lifespan in 2 cardiomyocyte-specific transgenic mouse models with enhanced versus reduced IGF1 receptor (IGF1R) signaling. Male mice with human IGF1R overexpression or dominant negative phosphoinositide 3-kinase mutation were examined at different life stages by echocardiography, invasive hemodynamics, and treadmill coupled to indirect calorimetry. In vitro assays included cardiac histology, mitochondrial respiration, ATP synthesis, autophagic flux, and targeted metabolome profiling, and immunoblots of key IGF1R downstream targets in mouse and human explanted failing and nonfailing hearts, as well.
Young mice with increased IGF1R signaling exhibited superior cardiac function that progressively declined with aging in an accelerated fashion compared with wild-type animals, resulting in heart failure and a reduced lifespan. In contrast, mice with low cardiac IGF1R signaling exhibited inferior cardiac function early in life, but superior cardiac performance during aging, and increased maximum lifespan, as well. Mechanistically, the late-life detrimental effects of IGF1R activation correlated with suppressed autophagic flux and impaired oxidative phosphorylation in the heart. Low IGF1R activity consistently improved myocardial bioenergetics and function of the aging heart in an autophagy-dependent manner. In humans, failing hearts, but not those with compensated hypertrophy, displayed exaggerated IGF1R expression and signaling activity.
Our findings indicate that the relationship between IGF1R signaling and cardiac health is not linear, but rather biphasic. Hence, pharmacological inhibitors of the IGF1 pathway, albeit unsuitable for young individuals, might be worth considering in older adults.</abstract><cop>United States</cop><pub>Lippincott Williams & Wilkins</pub><pmid>35616058</pmid><doi>10.1161/CIRCULATIONAHA.122.059863</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0001-6414-8707</orcidid><orcidid>https://orcid.org/0000-0003-4623-0330</orcidid><orcidid>https://orcid.org/0000-0003-0102-7902</orcidid><orcidid>https://orcid.org/0000-0003-2755-2860</orcidid><orcidid>https://orcid.org/0000-0003-3559-1130</orcidid><orcidid>https://orcid.org/0000-0002-3828-9562</orcidid><orcidid>https://orcid.org/0000-0002-4419-6821</orcidid><orcidid>https://orcid.org/0000-0002-5042-9054</orcidid><orcidid>https://orcid.org/0000-0002-2840-6454</orcidid><orcidid>https://orcid.org/0000-0002-9334-4405</orcidid><orcidid>https://orcid.org/0000-0002-6081-9558</orcidid><orcidid>https://orcid.org/0000-0002-0756-0014</orcidid><orcidid>https://orcid.org/0000-0003-3753-5394</orcidid><orcidid>https://orcid.org/0000-0002-9069-2930</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-7322 |
ispartof | Circulation (New York, N.Y.), 2022-06, Vol.145 (25), p.1853-1866 |
issn | 0009-7322 1524-4539 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9203038 |
source | MEDLINE; American Heart Association Journals; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals |
subjects | Aged Animals Health Promotion Humans Insulin-Like Growth Factor I - metabolism Life Sciences Longevity Male Mice Myocytes, Cardiac - metabolism Original s Phosphatidylinositol 3-Kinases - metabolism Receptor, IGF Type 1 - genetics Receptor, IGF Type 1 - metabolism |
title | Fine-Tuning Cardiac Insulin-Like Growth Factor 1 Receptor Signaling to Promote Health and Longevity |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T20%3A30%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fine-Tuning%20Cardiac%20Insulin-Like%20Growth%20Factor%201%20Receptor%20Signaling%20to%20Promote%20Health%20and%20Longevity&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=Abdellatif,%20Mahmoud&rft.date=2022-06-21&rft.volume=145&rft.issue=25&rft.spage=1853&rft.epage=1866&rft.pages=1853-1866&rft.issn=0009-7322&rft.eissn=1524-4539&rft_id=info:doi/10.1161/CIRCULATIONAHA.122.059863&rft_dat=%3Cproquest_pubme%3E2670061440%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2670061440&rft_id=info:pmid/35616058&rfr_iscdi=true |